Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial.

J. Harada (Kobe, Japan), K. Nagata (Kobe, Japan), K. Iwata (Kobe, Japan), A. Ishikawa (Kobe, Japan), K. Tomii (Kobe, Japan)

Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Session: Best abstracts in pulmonary rehabilitation and chronic care
Session type: Oral Presentation
Number: 167

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Harada (Kobe, Japan), K. Nagata (Kobe, Japan), K. Iwata (Kobe, Japan), A. Ishikawa (Kobe, Japan), K. Tomii (Kobe, Japan). Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial.. 167

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial
Source: ERJ Open Res, 6 (3) 00197-2020; 10.1183/23120541.00197-2020
Year: 2020



Acute effects of supplemental oxygen therapy (SOT) using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis (IPF) – a randomized cross-over trial
Source: International Congress 2019 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2019



Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial
Source: International Congress 2017 – New insights in chronic respiratory failure
Year: 2017



Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Efficacy of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomized controlled phase 3 trial
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016


Maintenance of exercise capacity following pulmonary rehabilitation in COPD: randomised controlled trial
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009



Effects of supplemental oxygen vs. room air in COPD patients: A randomized placebo-controlled trial
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015

Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial.
Source: Virtual Congress 2020 – Chronic cough: only symptom or disease?
Year: 2020




High-flow oxygen therapy vs non invasive ventilation: a prospective randomized cross-over physiological study of alveolar recruitment in acute respiratory failure
Source: International Congress 2019 – Current trends in noninvasive ventilation for acute respiratory failure
Year: 2019



High-flow oxygen therapy versus noninvasive ventilation: a randomised physiological crossover study of alveolar recruitment in acute respiratory failure
Source: ERJ Open Res, 7 (4) 00373-2021; 10.1183/23120541.00373-2021
Year: 2021



Acute hemodynamic effect of acetazolamide in patients with pulmonary hypertension whilst breathing normoxic and hypoxic air: a randomized cross-over trial
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Effects of continuous chest wall vibration on dyspnoea and exercise tolerance in patients with chronic obstructive pulmonary disease: a randomized controlled trial.
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial
Source: Eur Respir J 2010; 35: 571-577
Year: 2010



Effect of breathing oxygen-enriched air on exercise performance in patients with pulmonary hypertension in heart failure with preserved ejection fraction. Randomized, placebo-controlled, cross-over trial.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019
Year: 2019